Hepatica Invest OÜ
Private limited company
- 12888083
- EE101815217
- Harju maakond, Tallinn, Kristiine linnaosa, Mehaanika tn 12, 10616
Company Hepatica Invest OÜ has been registered on 31/07/2015. The status of the company is Active.
The net sales for 2024 were 146 901 euros. The net sales of Hepatica Invest OÜ decreased compared to 2023. The profit margin for 2024 is 22%. It has increased compared to 2023
The company's activity is Rental and operating of own or leased real estate.
Empower Your Business
See all our solutions to grow your business
General Information
Company name in the business register
Hepatica Invest OÜ
Company type
Private limited company
Registration number
12888083
D-U-N-S number
521881001
Registered
Jul 31, 2015 over 10 years ago
Registered capital
2,520 EUR
VAT number
EE101815217 from Sep 1, 2015 over 10 years
Status
Active
Contact data
Physical address
Harju maakond, Tallinn, Kristiine linnaosa, Mehaanika tn 12, 10616
E-mail address
Telephone
Quarterly taxes paid
Source: Estonian Tax and Customs Board
Responsible persons
| Name | Personal ID / Date of birth | Role | From |
|---|---|---|---|
| Toomas Laan | 36808×××××× | Management board member | Jul 31, 2015 |
| Alo Rauk | 36809×××××× | Management board member | Jul 31, 2015 |
Source: Estonian Business Registry (RIK)
Representation rights
- Every member of the Management Board may represent the private limited company in concluding all transactions.
Source: Estonian Business Registry (RIK)
Shareholders, supervisory board and other persons
D&B Risk Analytics Compliance Intelligence
D&B Risk Analytics Compliance Intelligence provides compliance teams with industry-leading data and modern capabilities to manage third-party compliance risk. Through intelligent and highly configurable policy-based workflows, D&B Risk Analytics Compliance Intelligence provides a state-of-the-art automated KYC/KYB monitoring solution that helps companies stay informed of risks in near real-time.
Product is designed to help compliance teams quickly and efficiently review, assess, monitor, and manage entities and related parties, including beneficial owners and significant control persons.
More information
can be found in
Financial information
| 2024 | 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 146 901 | ↓-0.12% | 147 082 | ↓-8.93% | 161 508 | ↑18.24% | 136 594 |
| Net profit (loss) | 32 507 | ↑6.86% | 30 421 | ↓-36.40% | 47 831 | ↑2.05% | 46 868 |
| No of employees | 0 | ⹀ | 0 | ⹀ | 0 | ⹀ | 0 |
What are the company's liabilities, current assets, equity and balance volume?
Dun & Bradstreet Finance Analytics gives you access to additional economic indicators - short-term liabilities, current assets, equity and balance volume. Everything you need for credit risk management across companies of all sizes worldwide.
More information
can be found in